Skip to Main Content
Skip Nav Destination

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression

Clin Sci (Lond) (2021) 135 (1): 35–52.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal